T1	Participants 107 145	cancer patients receiving chemotherapy
T2	Participants 284 315	patients receiving chemotherapy
T3	Participants 456 497	Patients receiving chemotherapy (N = 391)
T4	Participants 1449 1487	cancer patients receiving chemotherapy
